 SAN DIEGO, April 07, 2021 GLOBE NEWSWIRE -- Maravai LifeSciences Holdings, Inc. Maravai NASDAQ: MRVI, a global provider of life science reagents and services to researchers and biotech innovators, today announced the pricing of an upsized public offering of 18,000,000 shares of Maravais Class A common stock by certain selling stockholders that was previously announced, at a public offering price of 31.25 per share. The offering was upsized by 3,000,000 shares of Maravais Class A common stock from what was previously announced. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 2,700,000 shares of Maravais Class A common stock, which was upsized from 2,250,000 shares of Maravais Class A common stock. The offering is expected to close on April 12, 2021, subject to customary closing conditions. 